Morgan Stanley Evotec Se Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Evotec Se stock. As of the latest transaction made, Morgan Stanley holds 87,606 shares of EVO stock, worth $420,508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,606
Previous 43,707
100.44%
Holding current value
$420,508
Previous $512,000
33.79%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding EVO
# of Institutions
21Shares Held
347KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny82.8KShares$397,5120.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT47.8KShares$229,4250.19% of portfolio
-
Optiver Holding B.V. Amsterdam, P741.5KShares$199,2330.01% of portfolio
-
Black Rock Inc. New York, NY37.6KShares$180,4800.0% of portfolio
-
Cetera Investment Advisers Schaumburg, IL24.5KShares$117,8060.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.7B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...